I don’t know the answer to that. Obviously the B
Post# of 148290
(Total Views: 438)
Posted On: 05/19/2022 6:09:21 PM
I don’t know the answer to that. Obviously the Brazil trial was a debacle - to me it felt like it never really got off the ground – starting with the two month delay in being able to ship our product to the country due to customs issues - which we all knew about - so there is a big part of the answer that is complete public knowledge to all of us, or at least those who listen to calls during all of that.
I thought he was talking about why we aren’t continuing to enroll patients in Brazil - and on that front it is indeed because the pandemic is becoming endemic.
Regardless, I think we have bigger fish to fry than parcing through some language from a past conference call about a market that we have obviously abandoned, and for good reason. Let’s focus on Nash now, and eventually to cancer, and HIV, which is where we will all make our big money.
I thought he was talking about why we aren’t continuing to enroll patients in Brazil - and on that front it is indeed because the pandemic is becoming endemic.
Regardless, I think we have bigger fish to fry than parcing through some language from a past conference call about a market that we have obviously abandoned, and for good reason. Let’s focus on Nash now, and eventually to cancer, and HIV, which is where we will all make our big money.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼